Maxillary Sinus Augmentation with Decellularized Bovine Compact Particles: A Radiological, Clinical, and Histologic Report of 4 Cases
- PMID: 28349056
- PMCID: PMC5352871
- DOI: 10.1155/2017/2594670
Maxillary Sinus Augmentation with Decellularized Bovine Compact Particles: A Radiological, Clinical, and Histologic Report of 4 Cases
Abstract
Background. One of the most problematic regions for endosseous implants is the posterior maxilla, not only having poor bone density, but also lacking adequate vertical height as a result of sinus pneumatization. The purpose of the present study was a radiologic, histological, and histomorphometrical evaluation, in humans, of specimens retrieved from sinuses augmented with decellularized bovine compact particles, after a healing period of 6 months. Methods. Four patients, with atrophic resorbed maxillas, underwent a sinus lift augmentation with decellularized bovine compact bone from bovine femur. The size of the particles used was 0.25-1 mm. A total of four grafts and 5 biopsies were retrieved and processed to obtain thin ground sections with the Precise 1 Automated System. Results. The mean volume after graft elevation calculated for each of the 4 patients was 2106 mm3 in the immediate postoperative period (5-7 days), ranging from 1408.8 to 2946.4 mm3. In the late postoperative period (6 months) it was 2053 mm3, ranging from 1339.9 to 2808.9 mm3. Histomorphometry showed that newly formed bone was 36 ± 1.6% and marrow spaces were 34 ± 1.6%, while the residual graft material was 35 ± 1.4%. Conclusion. In conclusion, based on the outcome of the present study, Re-Bone® can be used with success in sinus augmentation procedures and 6 months are considered an adequate time for maturation before implant placement.
Conflict of interest statement
The author declares that there are no competing interests.
Figures









References
-
- Smiler D. G., Johnson P. W., Lozada J. L., et al. Sinus lift grafts and endosseous implants. Treatment of the atrophic posterior maxilla. Dental Clinics of North America. 1992;36(1):151–187. - PubMed
-
- Iezzi G., Piattelli A., Giuliani A., et al. Molecular, cellular and pharmaceutical aspects of bone grafting materials and membranes during maxillary Sinus-lift Procedures. Part 1: A General Overview. Current Pharmaceutical Biotechnology. 2017;18(1):19–32. doi: 10.2174/1389201017666161221155237. - DOI - PubMed
-
- Del Fabbro M., Testori T., Francetti L., Weinstein R. Systematic review of survival rates for implants placed in the grafted maxillary sinus. International Journal of Periodontics and Restorative Dentistry. 2004;24(6):565–577. - PubMed
-
- dos Anjos T., de Molon R., Paim P., Marcantonio E., Marcantonio E., Jr., Faeda R. Implant stability after sinus floor augmentation with deproteinized bovine bone mineral particles of different sizes: a prospective, randomized and controlled split-mouth clinical trial. International Journal of Oral and Maxillofacial Surgery. 2016;45(12):1556–1563. doi: 10.1016/j.ijom.2016.09.004. - DOI - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources